Mutations induced by (−)‐<i>anti</i>‐11<i>R</i>,12<i>S</i>‐dihydrodiol 13<i>S</i>,14<i>R</i>‐epoxide of dibenzo[<i>a,l</i>]pyrene in the coding region of the hypoxanthine phosphoribosyltransferase (<i>Hprt</i>) gene in Chinese hamster V79 cells

Environmental and Molecular Mutagenesis - Tập 41 Số 2 - Trang 131-139 - 2003
Brinda Mahadevan1, Wan‐Mohaiza Dashwood2, Andreas Luch3, Arta Pecaj2, Johannes Doehmer4, Albrecht Seidel5, Cliff Pereira6, William M. Baird2
1Department of Environmental & Molecular Toxicology, Agricultural and Life Sciences 1007, Oregon State University, Corvallis 97331-7302, USA.
2Department of Environmental & Molecular Toxicology and Department of Biochemistry & Biophysics, Agricultural and Life Sciences 1007, Oregon State University, Corvallis, Oregon
3Department of Cell Biology, Institute of Chemistry and Cell Biology, Harvard Medical School, Boston, Massachusetts
4GenPharmTox BioTechAG, Martinsried, Germany
5Biochemical Institute for Environmental Carcinogens , Grosshansdorf, Germany
6Department of Statistics , Oregon State University , Corvallis, Oregon

Tóm tắt

AbstractThe polycyclic aromatic hydrocarbon dibenzo[a,l]pyrene (DB[a,l]P) is an exceptionally potent carcinogen. Its direct DNA‐reactive metabolite, the fjord region (−)‐anti‐11R,12S‐dihydrodiol 13S,14R‐epoxide [(−)‐anti‐DB[a,l]PDE], was used to investigate induction of mutations in the coding region of the hypoxanthine phosphoribosyltransferase (Hprt) gene in Chinese hamster V79 cells. Cells exposed to 1–10 nM (−)‐anti‐DB[a,l]PDE exhibited a close dose‐responsive increase in the frequency of mutant clones resistant to 6‐thioguanine. RNA was isolated from mutant clones and cDNAs were prepared by reverse transcription. The coding region of the cDNA of the Hprt gene was amplified by polymerase chain reaction and sequenced. Analysis of the DNA base sequence changes induced by (−)‐anti‐DB[a,l]PDE indicated that base substitutions were the most prevalent mutations, followed by exon deletions. Among the groups of V79 cells treated with low concentrations of (−)‐anti‐DB[a,l]PDE, most displayed high selectivity for both A:T→T:A transversions and A:T→G:C transitions, while cells exposed to a higher dose (10 nM) formed predominantly G:C→T:A transversions. Also, the number of base substitutions per mutant clone increased with dose. In general, the mutation profiles induced by (−)‐anti‐DB[a,l]PDE exhibited a wide spectrum; in addition to base substitutions, deletions, insertions, frameshift mutations, as well as tandem mutations were detected. Analysis of the DNA adduct levels induced by (−)‐anti‐DB[a,l]PDE revealed that a concentration‐dependent increase in the level of adduct formation preceded the concentration‐dependent increase in mutational events in these cells and that an increasing proportion of DNA adducts at deoxyadenosine were formed with dose. The results of this study demonstrate a correspondence between the concentration and types of DNA adducts and the frequency and types of mutations induced by (−)‐anti‐DB[a,l]PDE in V79 cells. Environ. Mol. Mutagen. 41:131–139, 2003. © 2003 Wiley‐Liss, Inc.

Từ khóa


Tài liệu tham khảo

10.1093/carcin/16.11.2813

10.1093/carcin/16.8.1971

10.1073/pnas.75.11.5358

10.1021/tx020017q

10.1093/carcin/12.10.1939

10.1073/pnas.92.22.10422

10.1021/tx00011a011

10.1007/978-1-4615-0667-6_102

10.1126/science.274.5286.430

Dipple A, 1983, Evidence that binding of 7,12‐dimethylbenz[a]anthracene to DNA in mouse embryo cell cultures results in extensive substitution of both adenine and guanine residues, Cancer Res, 43, 4132

Dipple A, 1999, DNA reactions, mutagenic action and stealth properties of polycyclic aromatic hydrocarbon carcinogens, Int J Oncol, 14, 103

Harvey RG, 1991, Polycyclic aromatic hydrocarbons: chemistry and carcinogenicity

Hecker E, 1982, 41

10.1093/carcin/14.5.875

10.1073/pnas.73.2.607

Jerina DM, 1986, 11

10.1093/carcin/12.5.885

10.1016/0304-3835(92)90265-W

Levin W, 1986, Tumorigenicity of optical isomers of the diasteromeric bay‐region 3,4‐diol‐1,2‐epoxides of benzo[c]phenanthrene in murine tumor models, Cancer Res, 46, 2257

10.1093/carcin/15.11.2507

10.1021/tx970005i

10.1021/tx970236p

10.1093/carcin/20.10.1885

10.1021/tx9802724

10.3109/01902149809087376

10.1002/(SICI)1098-2280(1998)31:3<197::AID-EM1>3.0.CO;2-I

Pitot HC, 1990, Chemical carcinogenesis and mutagenesis, 70

10.1093/carcin/18.10.1955

Ralston SL, 1997, Stereoselective activation of dibenzo[a,l]pyrene and its trans‐11,12‐dihyrdrodiol to fjord region 11,12‐diol 13,14‐epoxides in a human mammary carcinoma MCF‐7 cell‐mediated V79 cell mutation assay, Chem Res Toxicol, 16, 2899

10.1016/S0027-5107(99)00016-0

Sambrook J, 1989, Molecular cloning: a laboratory manual

Sanger F, 1992, DNA sequencing with chain‐terminating inhibitors, Biotechnology, 24, 104

10.1021/jo00001a007

10.1093/carcin/20.12.2279

Slaga TJ, 1979, Marked differences in the skin tumor‐initiating activities of the optical enantiomers of the diastereomeric benzo[a]pyrene 7,8‐diol‐9,10‐epoxides, Cancer Res, 39, 67

10.1021/tx015546t

10.1021/tx970142f

10.1073/pnas.88.24.11227

Wei SJ, 1993, Dose‐dependent differences in the profile of mutations induced by (+)‐7R,8S‐dihydroxy‐9S,10R‐epoxy‐7,8,9,10‐tetrahydrobenzo[a]pyrene in the coding region of the hypoxanthine (guanine) phosphoribosyltransferase gene in Chinese hamster V79 cells, Cancer Res, 53, 3294

10.1093/carcin/15.8.1729

Wei SJ, 1996, Dose‐dependent differences in the mutational profiles of (−)‐(1R,2S,3S,4R)‐3,4‐dihydroxy‐1,2‐epoxy‐1,2,3,4‐tetrahydrobenzo[c]phenanthrene and its less carcinogenic enantiomer, Cancer Res, 56, 3695

10.1093/carcin/20.9.1689

10.1016/0006-291X(76)91246-8

Thông tin
Thông tin xuất bản

Environmental and Molecular Mutagenesis

Tập 41 Số 2

131-139

Thông tin tác giả